ACRC TRIALS
Dallas, TX
972. 354.1520
info@ACRCTrials.com

ACRC TRIALS offers the expertise and research staff to conduct Phase 2-4 adult and pediatric pharmaceutical and device studies in various therapeutic areas.

Baptist Health Lexington Clinical Research Center
Lexington, KY
859.260.6456
Micheal.stephens@bhsi.com

Baptist Health Lexington is a 391-bed medical research and education center providing healthcare, leading-edge technology and medical services to patients throughout Central and Eastern Kentucky.

FXM Clinical Research Miami
Miami, FL
305.220.5222
info@fxmresearch.com

FXM Clinical Research is a privately owned and operated clinical research site that conducts phase 1, 2, 3 and 4 trials specializing in dermatology.

Health Concepts
Rapid City, SD
605.348.4141
healthconcepts104@hotmail.com

Health Concepts is a state-of-the-art research center built in 2009 with complete technology for a wide range of research studies.

Kenneth Beer MD, PA
West Palm Beach, FL
561.600.4848
mdunn@beerdermatology.com

The center is a dermatology/dermatopathology center dedicated to general, surgical and pediatric dermatology, as well as cosmetic dermatology.

Los Alamitos Cardiovascular
Los Alamitos, CA
562.430.7533
riar@losalcardio.com

Los Alamitos Cardiovascular is a private practice that has been serving patients in Los Angeles and Orange counties for more than 38 years.

OsNET
Indian Harbour Beach, FL
321.773.7119
ConciseReport@earthlink.NET

OsNET is a multispecialty clinical research informal alliance of 10 sites located throughout nine states.

Tandem Clinical Research
Marrero, LA
504.934.8424
info@tandemclinicalresearch.com

Tandem Clinical Research is a dedicated, phase1-4 clinical trials center.

The Rogosin Institute
New York, NY
212.249.4659
bjsloan@nyp.org

The Rogosin Institute is an independent, nonprofit institution for research and healthcare specializing in kidney disease.

Wasatch Clinical Research
Salt Lake City, UT
801.288.0607
kgeorge@wasatchcrc.com

Wasatch Clinical Research, founded in 1999, has conducted more than 60 phase 2-4 trials and has 33 principal investigators and more than 70 sub-investigators and study coordinators.